These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 19474574)

  • 21. Utility of transesophageal echocardiography in identification of thrombogenic milieu in patients with atrial fibrillation (an ACUTE ancillary study).
    Thambidorai SK; Murray RD; Parakh K; Shah TK; Black IW; Jasper SE; Li J; Apperson-Hansen C; Asher CR; Grimm RA; Klein AL;
    Am J Cardiol; 2005 Oct; 96(7):935-41. PubMed ID: 16188520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transesophageal echocardiography before cardioversion of recurrent atrial fibrillation: does absence of previous atrial thrombi preclude the need of a repeat test?
    Shen X; Li H; Rovang K; Hee T; Holmberg MJ; Mooss AN; Mohiuddin SM
    Am Heart J; 2003 Oct; 146(4):741-5. PubMed ID: 14564332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin) in atrial fibrillation and TEE-guided cardioversion.
    Bechtold H; Gunzenhauser D; Sawitzki H; Fung S; Janssen D
    Z Kardiol; 2003 Jul; 92(7):532-9. PubMed ID: 12883837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency and significance of right atrial appendage thrombi in patients with persistent atrial fibrillation or atrial flutter.
    Cresti A; García-Fernández MA; Miracapillo G; Picchi A; Cesareo F; Guerrini F; Severi S
    J Am Soc Echocardiogr; 2014 Nov; 27(11):1200-7. PubMed ID: 25240491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transesophageal echocardiography-guided approach to cardioversion of atrial fibrillation.
    Leung DY; Grimm RA; Klein AL
    Prog Cardiovasc Dis; 1996; 39(1):21-32. PubMed ID: 8693093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Findings of transoesophageal echocardiogram in appropriately anticoagulated patients with persistent atrial fibrillation prior to planned cardioversion.
    Barysienė J; Žebrauskaitė A; Petrikonytė D; Marinskis G; Aidietienė S; Aidietis A
    BMC Cardiovasc Disord; 2017 Feb; 17(1):67. PubMed ID: 28228120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of auricular thrombosis before atrial flutter cardioversion: a 17-year transoesophageal echocardiographic study.
    Cresti A; García-Fernández MA; De Sensi F; Miracapillo G; Picchi A; Scalese M; Severi S
    Europace; 2016 Mar; 18(3):450-6. PubMed ID: 26017468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi.
    Manning WJ; Silverman DI; Gordon SP; Krumholz HM; Douglas PS
    N Engl J Med; 1993 Mar; 328(11):750-5. PubMed ID: 8437595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ACUTE trial. Transesophageal echocardiography to guide electrical cardioversion in atrial fibrillation. Assessment of Cardioversion Using Transesophageal Echocardiography.
    Asher CR; Klein AL
    Cleve Clin J Med; 2002 Sep; 69(9):713-8. PubMed ID: 12222975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of left atrial thrombus and dense spontaneous echo contrast in patients with short-term atrial fibrillation < 48 hours undergoing cardioversion: value of transesophageal echocardiography to guide cardioversion.
    Kleemann T; Becker T; Strauss M; Schneider S; Seidl K
    J Am Soc Echocardiogr; 2009 Dec; 22(12):1403-8. PubMed ID: 19880280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for thrombosis and spontaneous echocardiographic contrast with sludge in atrial fibrillation patients treated with oral anticoagulants before electrical cardioversion.
    Rekosz J; Karwowski J; Kowalik I; Wiktorska A; Wrzosek K; Solecki M; Szmarowska K; Szymańska A; Mierzejewska B; Syska-Sumińska J; Dłużniewski M
    Kardiol Pol; 2024; 82(5):516-526. PubMed ID: 38606742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardioversion in patients with atrial fibrillation and left atrial thrombi on initial transesophageal echocardiography: should transesophageal echocardiography be repeated before elective cardioversion? A cost-effectiveness analysis.
    Seto TB; Taira DA; Manning WJ
    J Am Soc Echocardiogr; 1999 Jun; 12(6):508-16. PubMed ID: 10359923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transesophageal echocardiography-guided cardioversion of atrial fibrillation. Selection of a low-risk group for immediate cardioversion.
    Fonseca N; Caetano F; Santos J; Seixo F; Bernardino L; Silvestre I; Cardoso P; Segurado F; Inês L
    Rev Port Cardiol; 2004 Mar; 23(3):365-75. PubMed ID: 15185562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indications for TEE before cardioversion for atrial fibrillation: implications for appropriateness criteria.
    Grewal GK; Klosterman TB; Shrestha K; Yarmohammadi H; Zurick AO; Varr BC; Tang WH; Lindsay BD; Klein AL
    JACC Cardiovasc Imaging; 2012 Jun; 5(6):641-8. PubMed ID: 22698535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of cerebral embolism after cardioversion of atrial fibrillation: a prospective study with transesophageal echocardiography and cerebral magnetic resonance imaging.
    Bernhardt P; Schmidt H; Hammerstingl C; Lüderitz B; Omran H
    J Am Soc Echocardiogr; 2005 Jun; 18(6):649-53. PubMed ID: 15947768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation.
    Klein AL; Grimm RA; Murray RD; Apperson-Hansen C; Asinger RW; Black IW; Davidoff R; Erbel R; Halperin JL; Orsinelli DA; Porter TR; Stoddard MF;
    N Engl J Med; 2001 May; 344(19):1411-20. PubMed ID: 11346805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of expedited anticoagulation in patients undergoing transesophageal echocardiographic-guided cardioversion.
    Wu LA; Chandrasekaran K; Friedman PA; Ammash NM; Ramakrishna G; Hart CY; Moon BS; Herges RM; Rosales AG; Malouf JF
    Am J Med; 2006 Feb; 119(2):142-6. PubMed ID: 16443416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should all patients undergo transesophageal echocardiography before electrical cardioversion of atrial fibrillation?
    Grimm RA; Stewart WJ; Black IW; Thomas JD; Klein AL
    J Am Coll Cardiol; 1994 Feb; 23(2):533-41. PubMed ID: 8294710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter.
    Arnold AZ; Mick MJ; Mazurek RP; Loop FD; Trohman RG
    J Am Coll Cardiol; 1992 Mar; 19(4):851-5. PubMed ID: 1545081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.